The Theranos founder and CEO will no longer be able to own or operate a medical lab for at least two years. » Read More
The California Coastal Commission wants to ban on-site breeding of whales.
The chain gives to those affected by Texas weather
Only 59 percent of workers are to work part of the last week of 2015.
Both carrieres owe a $158M settlement following unauthorized charges
The chief executive shoots down the idea that the company has been avoiding taxes on overseas profits.
Jack Welch, Jack Welch Management Institute executive chairman, discusses the disconnection between most business schools and best business practices.
Debra Corey, director of Reward Gateway, explains why some employees will do anything to avoid the annual Christmas party.
Toxic workers cost companies to train replacements they drive away.
Fishing boats carrying decomposed corpses have washed ashore in Japan in recent weeks.
The distillery behind Ketel One Vodka, is now in its 11th generation.
Private equity firms face numerous challenges before making a profit.
German public prosecutor are looking into possible evaded tax payments linked to rigging of CO2 emissions.
Saudi Arabian women can now work dangerous jobs.
Taxi owners and lenders are suing New York City and its Taxi and Limousine Commission.
Shares of Valeant are falling after the call, as questions remain on Philidor, with CNBC's Meg Tirrell.
Shares of Volkswagen are down another 10 percent this week. Fmr. GM Chairman Bob Lutz, shares his perspective on the emission scandal, and VW's admission that it sold 800,000 cars in Europe that misstated fuel consumption and CO2 levels.
CNBC's Dominic Chu reports Citron says it is "not dialing back on its warning on Valeant, but are dialing back on the focus on Citron to investigate and report the vast spectrum of claims now piling up against Valeant."
Truckers are earning higher salaries amid the industry's shortage of drivers.
Silicon Valley blood testing start-up Theranos. CNBC contributor Jessica Lessin, Founder & Editor-in-Chief of The Information, discusses the questions surrounding the business model of Theranos, and the future for growing private tech companies.
New York Times' Jim Stewart, discusses Silicon Valley blood testing start-up Theranos.